Your browser doesn't support javascript.
loading
Corrigendum: Randomized, Double Blind, Placebo Controlled, Clinical Trial to Study Ashwagandha Administration in Participants Vaccinated Against COVID-19 on Safety, Immunogenicity, and Protection With COVID-19 Vaccine-A Study Protocol.
Chopra, Arvind; Chavan-Gautam, Preeti; Tillu, Girish; Saluja, Manjit; Borse, Swapnil; Sarmukaddam, Sanjeev; Chaudhuri, Susmita; Rao, Bcs; Yadav, Babita; Srikanth, Narayanam; Patwardhan, Bhushan.
Afiliação
  • Chopra A; Center for Rheumatic Diseases, Pune, India.
  • Chavan-Gautam P; Center for Complementary and Integrative Health, Interdisciplinary School of Health Sciences, Savitribai Phule Pune University, Pune, India.
  • Tillu G; Center for Complementary and Integrative Health, Interdisciplinary School of Health Sciences, Savitribai Phule Pune University, Pune, India.
  • Saluja M; Center for Rheumatic Diseases, Pune, India.
  • Borse S; Center for Complementary and Integrative Health, Interdisciplinary School of Health Sciences, Savitribai Phule Pune University, Pune, India.
  • Sarmukaddam S; Center for Rheumatic Diseases, Pune, India.
  • Chaudhuri S; Translational Health Science and Technology Institute (THSTI), Faridabad, India.
  • Rao B; Central Council for Research in Ayurvedic Science, New Delhi, India.
  • Yadav B; Central Council for Research in Ayurvedic Science, New Delhi, India.
  • Srikanth N; Central Council for Research in Ayurvedic Science, New Delhi, India.
  • Patwardhan B; Center for Complementary and Integrative Health, Interdisciplinary School of Health Sciences, Savitribai Phule Pune University, Pune, India.
Front Med (Lausanne) ; 9: 888928, 2022.
Article em En | MEDLINE | ID: mdl-35433723

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline Idioma: En Revista: Front Med (Lausanne) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Índia País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline Idioma: En Revista: Front Med (Lausanne) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Índia País de publicação: Suíça